Research
Royal Society honours Dal oceanographer for globally recognized climate research
One of Canada's highest academic honours goes to Dal oceanographer Dr. Katja Fennel for her globally recognized contributions to climate research. Read more.
Featured News
Monday, September 14, 2026
Enabling pharmacists to prescribe preventive Lyme disease medication shifted hundreds of routine cases out of emergency departments, easing pressure on the health-care system, shows a new 色妹妹直播 study.
Tuesday, September 8, 2026
As it enters a new era, the MacEachen Institute of Public Policy and Governance is expanding its efforts to connect researchers, decision-makers, and communities on pressing national and regional issues.
Thursday, August 20, 2026
A new Dal-hosted research institute will connect researchers, students, partners and communities to advance AI research, learning and innovation rooted in Atlantic Canada.
Archives - Research
Monday, July 24, 2023
An effective national school food program can help build the foundations for a healthy population. That鈥檚 why Ottawa must limit the influence of the food industry on a national school food program.
Thursday, July 13, 2023
The challenge of getting a tracking device the size of a baseball on some of the world's largest, more elusive creatures isn't stopping a team of Dal researchers as they try to learn more about the movement, diet and lifestyle of several whale species.
Friday, June 30, 2023
Humans are exploiting more than one-third of the world's vertebrates and threatening the existence of more than 5,000 species, according to a global study looking at how human predation impacts biodiversity through consumption, trophy hunting and other activities.
Wednesday, June 28, 2023
Now ranked at 298 globally, 色妹妹直播 maintained twelfth place among Canadian universities and remains the top-ranked university in Atlantic Canada.
Tuesday, June 27, 2023
The federal government鈥檚 proposed Agile Licensing drug approval regulations mean Canada will have less information about the risks of new medicines, and higher costs.